Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.
about
Guidelines on the management of ascites in cirrhosisCould there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shuntEvaluation and Management of Hepatic Encephalopathy: Current Status and Future DirectionsTransjugular intrahepatic portosystemic shuntTreatment and management of ascites and hepatorenal syndrome: an updateThe effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathyTranscaval TIPS in patients with failed revision of occluded previous TIPSCerebral changes in hepatic encephalopathy.Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant.Current status of transjugular intrahepatic portosystemic shunts.A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis.TIPSS 10 years on.Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices - recommendations of the Working Group of the National Consultant for Gastroenterology.Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients.Management of cirrhotic ascitesLiver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis.Current trends in the treatment of hepatic encephalopathy.Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease.Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.Self-Expanding Metal Stent (SEMS): an innovative rescue therapy for refractory acute variceal bleedingHyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt CreationClinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding.Hepatic encephalopathy verified by psychometric testing and EEG in cirrhotic patients: effects of mesocaval interposition shunt or sclerotherapy.Preoperative assessment of the patient with liver disease.Functional hepatic flow in patients with liver cirrhosis.The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.Evaluation and management of patients with refractory ascites.Surgical portosystemic shunts and the Rex bypass in children: a single-centre experience.Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers.The transjugular intrahepatic portosystemic stent-shunt: a review of the literature and own experiences.The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.Role of self-expandable metal stents in acute variceal bleeding.Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts?Hepatic encephalopathy therapy: An overview.Beware of TIPPSters.Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.Clinical Images: Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy.Current management of refractory ascites in patients with cirrhosis.How I do it: flow-limiting stent for intractable encephalopathy following transjugular intrahepatic portosystemic shunt.
P2860
Q24676541-E16B25AB-E96C-4B2A-9874-F8EF5E2DEEB5Q26739786-57465336-9E6E-4B21-8C8C-383D28DDFA58Q26744689-C87D1CAE-1686-4733-B8A8-CDFD59EE8F5AQ26991832-9C4EC2CB-1723-412F-ABC1-7E3DA06E2016Q27000268-938DF684-18E3-4C9E-95E7-EFBEBC0728CFQ28290221-ECD630B7-0F22-4E9A-BCC0-BC9A6C76342FQ28344100-0827B2E2-FFAB-4302-B2C2-313AB716BF10Q32034877-C0DCEE75-EF41-4E32-8C34-BBAA79CEFCE1Q33558986-8121067C-027E-42C3-9D95-DF0FE5616932Q33631483-093D7A89-DCF9-445F-9043-23B250809461Q33788525-D33A8749-7A40-4237-9B40-6B7F2060A4DBQ33862574-C8282903-EBC7-4F9D-A56F-4BC556935DDDQ33941349-750FF9C2-92A2-44EF-80C0-6E8D1893E799Q34410410-10C87FB4-A7BC-414C-A022-D1D01352FF39Q34475601-3A5E45C0-2C71-40E8-ACE3-D1DA90C96CE8Q34545896-E35C5B1D-9108-46C6-820C-2E50D9CFC352Q34611198-E8B5BAC8-7133-4DCA-A900-99424DE694F6Q35207570-FDF5A240-0640-4438-8F4D-5FBA9B210266Q35435269-472541FA-54DB-4B99-9276-B903DF64BD52Q35579566-20C4B506-B9DF-44BD-8143-A5EA4B294002Q35667270-BD8AA4C8-7CE1-4608-873F-639B1BA0EC24Q35937782-66236AB9-D237-41D4-AB5A-FAFF46D49CA0Q36065996-73760613-EFD8-436C-954A-32249170A09DQ36243486-2E7D9236-ABEC-4CD7-ABFC-6F7397A5C2F3Q36502584-CF654C68-BC7C-40DD-9E9E-F96BF6823705Q36961977-83947F1F-7DCD-4541-A810-83D5E1CDB12FQ37122130-9E75C1B2-B2BA-4817-9390-E87FDD8F9DA6Q37231159-39767C93-0DA6-436C-ADD4-1C11174CA65CQ38254071-5C8C8741-1DBC-4087-B9AB-24E18ED2DE01Q41065907-43F39660-E9A6-486F-BCD8-B57A239042F8Q41842278-1B45C7E6-4E74-49A0-95BA-C178729677C3Q42285030-861C2052-DB35-4B7E-908D-AE18897511DCQ42593012-DD25411E-21FA-4059-87C8-E23062206BC0Q42593017-48B9C3BE-9B3A-41A3-8E43-C9FB863489ECQ42730495-19EC1552-C45D-45A2-B6B4-9D9D79316904Q43226420-49522637-50AC-445E-856C-C7327EDED5B6Q47114927-01D2D162-0DF4-406A-8BDD-C57E56B5C7EDQ47117810-105FE3DF-6702-48B6-8ADA-FCEE6343C98FQ47767771-7C335A87-F2EA-4319-BF9A-89DA120A0D3EQ50879077-C26CA9C1-8646-49FD-BC69-01E51F40FA25
P2860
Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Portosystemic encephalopathy a ...... prospective controlled study.
@en
Portosystemic encephalopathy a ...... prospective controlled study.
@nl
type
label
Portosystemic encephalopathy a ...... prospective controlled study.
@en
Portosystemic encephalopathy a ...... prospective controlled study.
@nl
prefLabel
Portosystemic encephalopathy a ...... prospective controlled study.
@en
Portosystemic encephalopathy a ...... prospective controlled study.
@nl
P2093
P1433
P1476
Portosystemic encephalopathy a ...... prospective controlled study.
@en
P2093
Cheatham AK
Freedman AM
Luketic VA
Purdum PP 3rd
Shiffman ML
P356
10.1016/0270-9139(94)90133-3
P407
P433
P577
1994-07-01T00:00:00Z